House Public Health Committee Pending Business April 3rd, 2023 The Committee took action on the following Bills: HB 44, as substituted, was reported favorably to the full house with the recommendation…
Read more
Pending Business. HB299 Committee Substitute reported favorably HB576 reported favorably HB1106 Complete Committee Substitute reported favorably HB1488 Complete Committee Substitute reported favorably HB1890 Complete Committee Substitute reported favorably HB2767 reported…
Read more
This summary contains supplemental information from reliable sources where that information provides clarity to the issues being discussed. Power Point tables used in the presentations may also be used in…
Read more
The Senate Committee on Health and Human Services met to consider the following. SB25 SB26 SB52 SB177 SB265 SB299 SB301 SB403 SB426 SB1024 SB1583 All bills were left pending public…
Read more
The Committee on Public Health met on March 20th to consider pending business and the following: HB 44 HB 81 HB 1106 . HB 1313 HB 1890 HB 1998 HB 2726 …
Read more
The Committee on Public Health met on March 13th to consider the following: HB181, HB248, HB299, HB362, HB861, HB 1190, HB 1488, HB 1510, HB 1805 and Pending Business. Committee…
Read more
The Senate Committee on Health and Human Services met to consider the following: SB241 (withdrawn), SB415, SB458, SB497, SB545, SB576, SB745, SB780. All bills were left pending public comment. Following…
Read more
The Committee on Public Health met to consider the following: HB49, HB112, HB173, HB233, HB576, and HB624. Typically bills are held in committee for at least one week. For a…
Read more
The Select Committee on Health Care Reform met to hear invited testimony only over the following interim charges. 1. Study the implications of excessive health care costs on the efficacy…
Read more
2. Drug Prices and Accessibility Panel 1: Overview of Prescription Drug Coverage and Reimbursement Antonio Ciaccia, antonio@3axisadvisors.com Background: CEO, 46brooklyn; President, 3 Axis Advisors Robert Popovian Debbie Garza, dgarza@texaspharmacy.org Background:…
Read more